Fig. 7From: Mesoporous silica nanotechnology: promising advances in augmenting cancer theranosticsGraphical representation of drug-loaded theranostic MSN platform designed to have pH-sensitivity as a trigger for drug release to elicit a chemotherapeutic effectBack to article page